Brief: Kissei Pharmaceutical says marketing approval for "Beova® Tablets 50mg" for treatment of overactive bladder
21/09/2018 07:54
Sept 21(Reuters) - Kissei Pharmaceutical Co Ltd 4547.T
* Says Kissei Pharmaceutical Co Ltd and KYORIN Holdings,
Inc.
4569.T jointly announced today that KYORIN Pharmaceutical Co.,
Ltd., a subsidiary of KYORIN Holdings, Inc., received approval
from the Ministry of Health, Labour and Welfare as of September
21, 2018 to market 'Beova® Tablets 50mg' for the treatment of
overactive bladder
Source text in Japanese:https://goo.gl/YDf2u5
Further company coverage: 4547.T 4569.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: huafang.zhang.reuters.com@reuters.net))